340B Drug Pricing Program

Alliance of Community Health Centers Sues State to Preserve Benefits of the Federal 340B Drug Pricing Program

Retrieved on: 
Thursday, October 29, 2020
Health, Health Resources and Services Administration, Healthcare in the United States, 340B Drug Pricing Program, Drug pricing, Federally Qualified Health Center, Medicaid, Healthy Way LA, Healthcare Systems Bureau

SACRAMENTO, Calif., Oct. 29, 2020 /PRNewswire/ -- The Community Health Center Alliance for Patient Access (CHCAPA) has filed suit in federal court contesting the state's plan to 'carve out' the pharmacy benefit from Medicaid managed care, thus preventing community health centers from benefiting from the Federal 340B Drug Pricing Program.

Key Points: 
  • SACRAMENTO, Calif., Oct. 29, 2020 /PRNewswire/ -- The Community Health Center Alliance for Patient Access (CHCAPA) has filed suit in federal court contesting the state's plan to 'carve out' the pharmacy benefit from Medicaid managed care, thus preventing community health centers from benefiting from the Federal 340B Drug Pricing Program.
  • "The state's ill-conceived action threatens the ability of many community health centers to provide critical programs to uninsured and low-income families across the state," said Anthony White, President of the CHCAPA, a statewide organization of federally qualified health centers, serving 2.1 million patients.
  • "Medi-Cal patients depend on us for access to comprehensive primary and preventive health care," said Leslie Abasta-Cummings, CEO of Livingston Community Health, which operates six health centers in the Central Valley.
  • "Excluding our centers from the 340B Program will jeopardize patients' access to care, increase risk for health problems and raise costs," said Ronald E. Castle, CEO at Community Health Centers of the Central Coast, Inc., where he oversees 30 health centers and seven mobile dental and medical units.

Sentry stands with Ryan White Clinics as study highlights importance of funding and 340B program in managing HIV/AIDS epidemic

Retrieved on: 
Monday, October 26, 2020
Health Resources and Services Administration, Drug pricing, 340B Drug Pricing Program, HIV/AIDS, Ryan White

"Sentry is proud to support Ryan White Clinics for 340B Access and its members through advocacy, technology and the expertise they need to maximize their 340B benefits and continue providing high-quality care to their patients."

Key Points: 
  • "Sentry is proud to support Ryan White Clinics for 340B Access and its members through advocacy, technology and the expertise they need to maximize their 340B benefits and continue providing high-quality care to their patients."
  • Ryan White providers are also eligible for the federal 340B Drug Discount Program and use it to expand affordable access to expensive and life-saving HIV/AIDS medications.
  • It examines access to HIV care and the important roles of the Ryan White HIV/AIDS Program and the 340B program for their clients and for viral suppression.
  • It also discusses policies related to Ryan White program income for clinic grantees and funding sources.

Progressive Care to Expand 340B Third Party Administrator Services Nationwide

Retrieved on: 
Thursday, October 22, 2020
Health, Articles, Pharmacy, Symbols, Clinical pharmacology, Pharmaceuticals policy, Medicinal chemistry, Forward-looking statement, Prescription drug, Medical prescription, Medication therapy management, 340B Drug Pricing Program

Progressive Care Inc. (OTCQB: RXMD), through its subsidiaries, is a Florida health services organization and provider of prescription pharmaceuticals, compounded medications, provider of tele-pharmacy services, the sale of anti-retroviral medications, medication therapy management (MTM), the supply of prescription medications to long-term care facilities, and health practice risk management.

Key Points: 
  • Progressive Care Inc. (OTCQB: RXMD), through its subsidiaries, is a Florida health services organization and provider of prescription pharmaceuticals, compounded medications, provider of tele-pharmacy services, the sale of anti-retroviral medications, medication therapy management (MTM), the supply of prescription medications to long-term care facilities, and health practice risk management.
  • Such forward-looking statements reflect the Companys expectations about its future operating results, performance, and opportunities that involve substantial risks and uncertainties.
  • These statements include but are not limited to statements regarding our planned expansion of ClearMetrX 340B third party administration services nationwide and future demand for our services.
  • When used herein, the words anticipate, believe, estimate, upcoming, plan, target, intend and expect and similar expressions, as they relate to Progressive Care Inc., its subsidiaries, or its management, are intended to identify such forward-looking statements.

NACHC Files Suit Against HHS To Defend The 340B Drug Discount Program From Rx Manufacturer Attacks

Retrieved on: 
Wednesday, October 21, 2020
Health Resources and Services Administration, Drug pricing, 340B Drug Pricing Program

BETHESDA, Md., Oct. 21, 2020 /PRNewswire/ -- The National Association of Community Health Centers (NACHC) has filed suit to take action in response to recent moves by drug manufacturers to dismantle the health center federal 340B drug discount program.

Key Points: 
  • BETHESDA, Md., Oct. 21, 2020 /PRNewswire/ -- The National Association of Community Health Centers (NACHC) has filed suit to take action in response to recent moves by drug manufacturers to dismantle the health center federal 340B drug discount program.
  • The 340B program is critical for health centers' ability to make medications affordable for patients, and to generate savings that are used to expand access to other services.
  • NACHC estimates that 10 million low-income patients will suffer reduced access to health center services and affordable medicine unless HHS acts now to protect the program.
  • NACHC's suit presses HHS to promulgate administrative dispute resolution ("ADR") regulations and implement a process to adjudicate and remedy the 340B violations.

Advocates Stand Up Against AstraZeneca to Save Drug Discount Program for Vulnerable Populations

Retrieved on: 
Tuesday, October 13, 2020
Infectious diseases, Public policy, Government, Healthcare reform, Philanthropy, AIDS, Pharmaceutical, Health, Public policy, Foundation, Other Policy Issues, Health, Health Resources and Services Administration, Drug pricing, Pharmaceuticals policy, 340B Drug Pricing Program, Prescription drug, American Society of Health-System Pharmacists, Lifeline, Healthcare Systems Bureau, Infectious diseases, Public policy, Government, Healthcare reform, Philanthropy, AIDS, Pharmaceutical, Health, Public policy, Foundation, Other Policy Issues, Health, Health Resources and Services Administration, Drug pricing, Pharmaceuticals policy, 340B Drug Pricing Program, Prescription drug, American Society of Health-System Pharmacists, Lifeline, Healthcare Systems Bureau

The federal 340B Drug Discount Program is a lifeline that allows safety net providers, including HIV/AIDS clinics receiving funding through the Ryan White program, to obtain prescription drugs at below-retail prices.

Key Points: 
  • The federal 340B Drug Discount Program is a lifeline that allows safety net providers, including HIV/AIDS clinics receiving funding through the Ryan White program, to obtain prescription drugs at below-retail prices.
  • The program was established with bipartisan support as part of the Veterans Health Care Act of 1992.
  • The program also benefits qualified 340B covered entities such as non-profit rural health facilities, community clinics and childrens hospitals that serve vulnerable populations.
  • AstraZeneca has launched an assault on a federal drug discount program essential to the safety net of our nations health care, stated John Hassell, AHFs national director of advocacy.

PointCare announces new API to help screen uninsured patients for healthcare coverage, sees a 45.8% percent increase in Medicaid approvals.

Retrieved on: 
Tuesday, October 13, 2020
Healthcare in the United States, Health in the United States, Articles, Health, Health insurance coverage in the United States, Federally Qualified Health Center, Revenue Cycle Management, Health insurance, 340B Drug Pricing Program, Safety net hospital

This software allows hospitals, Revenue Cycle Management (RCM) companies, and other healthcare organizations to screen uninsured or self-pay patients in 90 seconds for all reimbursable and retroactive healthcare insurance and benefit options nationwide.

Key Points: 
  • This software allows hospitals, Revenue Cycle Management (RCM) companies, and other healthcare organizations to screen uninsured or self-pay patients in 90 seconds for all reimbursable and retroactive healthcare insurance and benefit options nationwide.
  • Traditionally, uninsured or self-pay patients who visit healthcare facilities for emergency, inpatient, or outpatient care are screened manually, if at all.
  • Healthcare organizations are also affected, as they lose revenue from high production departments and must find financial resources to support critically ill, uninsured patients.
  • PointCare, founded in 2012, serves Federally Qualified Health Centers (FQHCs), hospitals, and Revenue Cycle Managers (RCMs) by building technology to help better manage uninsured populations.

New Analysis Shows Contract Pharmacies Financially Gain From 340B Program With No Clear Benefit to Patients

Retrieved on: 
Thursday, October 8, 2020
Health, Health Resources and Services Administration, Articles, Drug pricing, 340B Drug Pricing Program, Healthcare reform in the United States, Pharmaceuticals policy, Health insurance coverage in the United States, Prescription drug, Pharmacy

Congress created the 340B program to help safety-net providers, including certain qualifying hospitals and federally-funded clinics, access discounts on prescription medicines for low-income or uninsured patients.

Key Points: 
  • Congress created the 340B program to help safety-net providers, including certain qualifying hospitals and federally-funded clinics, access discounts on prescription medicines for low-income or uninsured patients.
  • Analysis after analysis shows there is explosive growth in the program, but there is little to no clear evidence that this growth has benefited low-income and vulnerable patients.
  • GAO found that more than half of 340B hospitals surveyed reported that they did not share discounts with patients at their contract pharmacies.
  • OIG found similar evidence, noting some 340B hospitals "do not offer the 340B price to uninsured patients in any of their contract pharmacy arrangements.

More than 66% of Health Systems and Hospitals Use Automation Tools for Revenue Cycle Operations, According to Survey

Retrieved on: 
Thursday, October 8, 2020
Automation, Health system, 340B Drug Pricing Program

The majority of health systems and hospitals, (more than 66 percent) say they are now using or implementingautomation in their revenue cycle operations.

Key Points: 
  • The majority of health systems and hospitals, (more than 66 percent) say they are now using or implementingautomation in their revenue cycle operations.
  • The majority of health systems and hospitals (66 percent) are now using automation in their revenue cycle operations.
  • According to the survey, health systems (versus hospitals) are more likely to be currently using or implementing automation tools in their revenue cycle operations.
  • Health systems (versus hospitals) are statistically more likely to have automation in their revenue cycle operations.

Omnicell Completes Acquisition of Pharmaceutical Strategy Group’s Leading 340B Software-Enabled Service Business

Retrieved on: 
Thursday, October 1, 2020
Data management, Health, Technology, Other Technology, Other Health, Software, Pharmaceutical, Drug pricing, Health Resources and Services Administration, 340B Drug Pricing Program, Pharmacy

Omnicell, Inc. (NASDAQ:OMCL), a leading provider of medication management solutions and adherence tools for health systems and pharmacies, today announced that it has completed the previously announced acquisition of Pharmaceutical Strategies Groups (PSG) 340B Link business, pursuant to the terms and conditions of an Equity Purchase Agreement.

Key Points: 
  • Omnicell, Inc. (NASDAQ:OMCL), a leading provider of medication management solutions and adherence tools for health systems and pharmacies, today announced that it has completed the previously announced acquisition of Pharmaceutical Strategies Groups (PSG) 340B Link business, pursuant to the terms and conditions of an Equity Purchase Agreement.
  • The federal 340B Drug Pricing Program has provided financial assistance to hospitals serving vulnerable communities for more than 25 years.
  • The acquired 340B Link business recorded approximately $35 million of total revenue (unaudited) for the 12 months ended June 30, 2020.
  • Since 1992, Omnicell has been committed to transforming the pharmacy care delivery model to dramatically improve outcomes and lower costs.

Media Briefing: Why Community Health Centers Must Defend The 340B Drug Discount Program Against Manufacturer Attacks

Retrieved on: 
Tuesday, September 15, 2020
Articles, Health, Community health center, Health insurance coverage in the United States, Cisco Webex, Pharmacist, Health Resources and Services Administration, 340B Drug Pricing Program

Jangus Whitner, PharmD, Clinical Pharmacist & 340B Program Manager,

Key Points: 
  • Jangus Whitner, PharmD, Clinical Pharmacist & 340B Program Manager,
    Attendees can access the press conference at the following WebEx link: https://nachc.webex.com/nachc/onstage/g.php?MTID=ebe5b9866623d9810b6d45d...
    Health centers serve nearly 30 million patients nationwide, including veterans, people who have lost their jobs and health insurance in the economic decline and essential workers infected with non-acute COVID-19.
  • The cost of medicines can easily push them further into poverty, disease, and even death.
  • Established in 1971, the National Association of Community Health Centers (NACHC) serves as the national voice for America's Health Centers and as an advocate for health care access for the medically underserved and uninsured.
  • View original content to download multimedia: http://www.prnewswire.com/news-releases/media-briefing--why-community-he...